HYDREA Side Effects

7009267-7 | Interstitial Lung Disease
on Sep 17, 2010 Male patient from FRANCE , 75 years of age, was diagnosed with myelofibrosis and was treated with Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Hydrea dosage: . During the same period patient was treated with ALLOPURINOL (1 Tablet) (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6978397-8 | Arthralgia, Burning Sensation, Fatigue, Pain In Extremity, Rash Macular
Patient was taking Hydrea (View Usage). Patient had the following side effects: arthralgia, burning sensation, fatigue, pain in extremity, rash macular on Sep 07, 2010 from CANADA Additional patient health information: Female patient , 82 years of age, was diagnosed with myeloproliferative disorder, polycythaemia vera, thrombocytosis and. Hydrea dosage: 1df=1 Tab.

6977071-1 | Gait Disturbance, Pain, Skin Ulcer
Adverse event was reported on Sep 06, 2010 by a Female patient taking Hydrea (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: FRANCE , 63 years of age, After Hydrea was administered, patient had the following side effects: gait disturbance, pain (What is pain?), skin ulcer. During the same period patient was treated with TAHOR (View Tahor Review and Tahor Label ), LODOZ (View Lodoz Review and Lodoz Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

6966773-9 | Blood Urine Present, Chills, Decreased Appetite, Diarrhoea, Disorientation, Headache, Pyrexia
on Sep 01, 2010 Male patient from UNITED KINGDOM , 77 years of age, was diagnosed with polycythaemia vera and was treated with Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: blood urine present, chills, decreased appetite, diarrhoea, disorientation, headache (What is headache?), pyrexia. Hydrea dosage: . Patient was hospitalized.


6966763-6 | Cognitive Disorder, Memory Impairment
on Sep 03, 2010 Male patient from UNITED KINGDOM , 86 years of age, was diagnosed with polycythaemia and was treated with Hydrea (View Usage). Patient had the following side effects: cognitive disorder, memory impairment. Hydrea dosage: Dosage:monday To Friday. During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ).

6964841-9 | Blood Bilirubin Increased, Cytolytic Hepatitis, Hepatic Steatosis
Patient was taking Hydrea (View Usage). After Hydrea was administered, patient had the following side effects: blood bilirubin increased, cytolytic hepatitis, hepatic steatosis on Sep 01, 2010 from FRANCE Additional patient health information: Female patient , 73 years of age, weighting 293.2 lb, was diagnosed with acute myeloid leukaemia, neoplasm prophylaxis, vomiting and. Hydrea dosage: . During the same period patient was treated with FASTURTEC (View Fasturtec Review and Fasturtec Label ), ZAVEDOS (View Zavedos Review and Zavedos Label ), BELUSTINE (View Belustine Review and Belustine Label ), ARACYTINE (View Aracytine Review and Aracytine Label ), ZOFRAN (1df= 8mg/4ml) (View Zofran Review and Zofran Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6961203-5 | Blood Bilirubin Increased, Cytolytic Hepatitis, Hepatic Steatosis
Adverse event was reported on Aug 30, 2010 by a Female patient taking Hydrea (View Usage) (Dosage: ) was diagnosed with acute myeloid leukaemia, neoplasm prophylaxis, vomiting and. Location: FRANCE , 73 years of age, weighting 293.2 lb, Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, cytolytic hepatitis, hepatic steatosis. During the same period patient was treated with FASTURTEC (View Fasturtec Review and Fasturtec Label ), ZAVEDOS (View Zavedos Review and Zavedos Label ), BELUSTINE (View Belustine Review and Belustine Label ), ARACYTINE (View Aracytine Review and Aracytine Label ), ZOFRAN (1df= 8mg/4ml) (View Zofran Review and Zofran Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6959509-9 | Bronchitis, Chest Pain, Eye Swelling, Fluid Retention, Joint Swelling, Platelet Count Increased, Pneumonia, Weight Increased
on Aug 26, 2010 Female patient from UNITED STATES , 63 years of age, was treated with Hydrea (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), chest pain (What is chest pain?), eye swelling, fluid retention, joint swelling, platelet count increased, pneumonia (What is pneumonia?), weight increased. Hydrea dosage: . During the same period patient was treated with PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

6943076-X | Cognitive Disorder, Memory Impairment, Polycythaemia
on Aug 18, 2010 Male patient from UNITED KINGDOM , 86 years of age, was treated with Hydrea (View Usage). After Hydrea was administered, patient had the following side effects: cognitive disorder, memory impairment, polycythaemia. Hydrea dosage: Dosage:monday To Friday. During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ).

6943074-6 | Blood Bilirubin Increased, Cytolytic Hepatitis, Hepatic Steatosis
Patient was taking Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, cytolytic hepatitis, hepatic steatosis on Aug 20, 2010 from FRANCE Additional patient health information: Female patient , 73 years of age, weighting 293.2 lb, was diagnosed with acute myeloid leukaemia, neoplasm prophylaxis, vomiting and. Hydrea dosage: . During the same period patient was treated with FASTURTEC (View Fasturtec Review and Fasturtec Label ), ZAVEDOS (View Zavedos Review and Zavedos Label ), BELUSTINE (View Belustine Review and Belustine Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ZOFRAN (1df= 8mg/4ml) (View Zofran Review and Zofran Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6883773-8 | Squamous Cell Carcinoma
Adverse event was reported on Jul 26, 2010 by a Female patient taking Hydrea (View Usage) (Dosage: Df=tabs) was diagnosed with polycythaemia vera and. Location: FRANCE , 82 years of age, Patient had the following side effects: squamous cell carcinoma.

6882448-9 | Renal Failure
on Jul 21, 2010 Male patient from UNITED STATES , 68 years of age, weighting 165.3 lb, was diagnosed with myelofibrosis and was treated with Hydrea (View Usage). After Hydrea was administered, patient had the following side effects: renal failure. Hydrea dosage: . Patient was hospitalized.

6844722-1 | Skin Discolouration, Type 2 Diabetes Mellitus
on Jul 12, 2010 Male patient from FRANCE , 67 years of age, weighting 213.8 lb, was diagnosed with thrombocytosis and was treated with Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: skin discolouration, type 2 diabetes mellitus. Hydrea dosage: Started In Sept/oct2008;1df:2 Caps/day And 3 Caps/day On Alternate Days. During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ).

6801692-X | Overgrowth Bacterial
Patient was taking Hydrea (View Usage). Patient had the following side effects: overgrowth bacterial on Jun 24, 2010 from JAPAN Additional patient health information: Female patient , 79 years of age, was diagnosed with essential thrombocythaemia and. Hydrea dosage: Also Taken On Oct2009. Patient was hospitalized.

6796414-5 | Allergy To Chemicals, Blood Potassium Increased, Candidiasis, Fatigue, Hypersensitivity, Pain Of Skin, Photosensitivity Reaction, Rash
Adverse event was reported on Jun 17, 2010 by a Female patient taking Hydrea (View Usage) (Dosage: Reduced To 400mg And Than To 300mg 1gm/day) was diagnosed with essential thrombocythaemia and. Location: UNITED STATES , 70 years of age, weighting 160.9 lb, After Hydrea was administered, patient had the following side effects: allergy to chemicals, blood potassium increased, candidiasis, fatigue, hypersensitivity, pain of skin, photosensitivity reaction, rash (What is rash?). During the same period patient was treated with DROXIA (Dosage Form = Tablet) (View Droxia Review and Droxia Label ), SINGULAIR (View Singulair Review and Singulair Label ), ALLEGRA (View Allegra Review and Allegra Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), AMBIEN (View Ambien Review and Ambien Label ), CANDID B (View Candid B Review and Candid B Label ).

6795747-6 | Cough, Depression
on Jun 23, 2010 Male patient from FRANCE , 61 years of age, weighting 132.3 lb, was diagnosed with chronic myeloid leukaemia, polycythaemia and was treated with Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: cough, depression (What is depression?). Hydrea dosage: Received For Atleast 6 Years.. During the same period patient was treated with PURINETHOL (View Purinethol Review and Purinethol Label ), PREVISCAN (View Previscan Review and Previscan Label ), METFORMIN (View Metformin Review and Metformin Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), BECLOMETASONE DIPROPIONATE+FORMOTEROL FUMARATE (View Beclometasone Dipropionate+formoterol Fumarate Review and Beclometasone Dipropionate+formoterol Fumarate Label ), MIANSERIN (View Mianserin Review and Mianserin Label ), TETRALYSAL (View Tetralysal Review and Tetralysal Label ).

6791058-3 | Overgrowth Bacterial
on Jun 16, 2010 Female patient from JAPAN , 79 years of age, was diagnosed with essential thrombocythaemia and was treated with Hydrea (View Usage). Patient had the following side effects: overgrowth bacterial. Hydrea dosage: Also Taken On Oct2009. Patient was hospitalized.

6785255-0 | Platelet Count Increased, Red Blood Cell Count Increased
Patient was taking Hydrea (View Usage). After Hydrea was administered, patient had the following side effects: platelet count increased, red blood cell count increased on Jun 16, 2010 from FRANCE Additional patient health information: Female patient , 82 years of age, was diagnosed with thrombocytosis and. Hydrea dosage: Since Jan2010 Capsule's Content Disssolved Into Coffee And Taken.

6783451-X | Interstitial Lung Disease
Adverse event was reported on Jun 14, 2010 by a Male patient taking Hydrea (View Usage) (Dosage: ) was diagnosed with thrombocytopenia and. Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Patient was hospitalized.

6772826-0 | Blood Lactate Dehydrogenase Increased, Blood Triglycerides Abnormal, Cholestasis, Histiocytosis Haematophagic, Hypokalaemia, Hyponatraemia, Platelet Count Decreased, Pyrexia
on Jun 10, 2010 Male patient from FRANCE , 58 years of age, was diagnosed with essential thrombocythaemia and was treated with Hydrea (View Usage). Patient had the following side effects: blood lactate dehydrogenase increased, blood triglycerides abnormal, cholestasis, histiocytosis haematophagic, hypokalaemia, hyponatraemia, platelet count decreased, pyrexia. Hydrea dosage: . During the same period patient was treated with ALLOPURINOL (Tab) (View Allopurinol Review and Allopurinol Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), TAHOR (View Tahor Review and Tahor Label ), COVERSYL (View Coversyl Review and Coversyl Label ), NEXIUM (View Nexium Review and Nexium Label ), PIASCLEDINE (Caps) (View Piascledine Review and Piascledine Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

6753670-7 | Platelet Count Increased, Red Blood Cell Count Increased
on May 28, 2010 Female patient from FRANCE , 82 years of age, was diagnosed with thrombocytosis and was treated with Hydrea (View Usage). After Hydrea was administered, patient had the following side effects: platelet count increased, red blood cell count increased. Hydrea dosage: Since Jan2010 Capsule's Content Disssolved Into Coffee And Taken.

6751180-4 | Skin Ulcer, Vascular Occlusion
Patient was taking Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: skin ulcer, vascular occlusion on May 28, 2010 from FRANCE Additional patient health information: Male patient , 38 years of age, was diagnosed with sickle cell anaemia and. Hydrea dosage: . During the same period patient was treated with PRAXILENE (Tabs) (View Praxilene Review and Praxilene Label ), SPECIAFOLDINE (Tab) (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

6751165-8 | Blood Glucose Increased, Glycosylated Haemoglobin Increased, Skin Discolouration
Adverse event was reported on May 27, 2010 by a Male patient taking Hydrea (View Usage) (Dosage: Started In Sept/oct2008;1df:2 Caps/day And 3 Caps/day On Alternate Days) was diagnosed with thrombocytosis and. Location: FRANCE , 69 years of age, Patient had the following side effects: blood glucose increased, glycosylated haemoglobin increased, skin discolouration. During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ).

6749123-2 | Cough, Depression
on May 27, 2010 Male patient from FRANCE , 76 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Hydrea (View Usage). After Hydrea was administered, patient had the following side effects: cough, depression (What is depression?). Hydrea dosage: Received For Atleast 6 Years.. During the same period patient was treated with PURINETHOL (View Purinethol Review and Purinethol Label ), PREVISCAN (View Previscan Review and Previscan Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), BECLOMETASONE DIPROPIONATE+FORMOTEROL FUMARATE (View Beclometasone Dipropionate+formoterol Fumarate Review and Beclometasone Dipropionate+formoterol Fumarate Label ), MIANSERIN (View Mianserin Review and Mianserin Label ), TETRALYSAL (View Tetralysal Review and Tetralysal Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).

6742355-9 | Acute Myeloid Leukaemia
on May 18, 2010 Female patient from FRANCE , 57 years of age, was diagnosed with breast cancer (What is breast cancer?), myelofibrosis and was treated with Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia. Hydrea dosage: . During the same period patient was treated with ETOPOSIDE (6 Iv Cycles) (View Etoposide Review and Etoposide Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), XAGRID (View Xagrid Review and Xagrid Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ). Patient was hospitalized.

6739997-3 | Diabetes Mellitus Inadequate Control, Necrosis
Patient was taking Hydrea (View Usage). Patient had the following side effects: diabetes mellitus inadequate control, necrosis on May 21, 2010 from FRANCE Additional patient health information: Female patient , 74 years of age, was diagnosed with thrombocytosis, diabetes mellitus and. Hydrea dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ).

6736510-1 | Blood Uric Acid Increased, Dry Skin, Increased Appetite, Overdose, Pain
Adverse event was reported on May 17, 2010 by a Female patient taking Hydrea (View Usage) (Dosage: Dose Increased Into 5g,then 2g Is Maintained) was diagnosed with leukaemia and. Location: BRAZIL , 40 years of age, After Hydrea was administered, patient had the following side effects: blood uric acid increased, dry skin, increased appetite, overdose, pain (What is pain?). Patient was hospitalized.

6723488-X | Thrombocytosis
on May 10, 2010 Female patient from UNITED STATES , 63 years of age, was treated with Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytosis. Hydrea dosage: .

6721428-0 | Breast Cancer
on May 04, 2010 Female patient from BRAZIL , 70 years of age, weighting 136.7 lb, was treated with Hydrea (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Hydrea dosage: Dosage Taken About 15 Years Ago.. During the same period patient was treated with LETROZOLE (View Letrozole Review and Letrozole Label ), ISOFLAVONE (View Isoflavone Review and Isoflavone Label ), PLANTABEN (View Plantaben Review and Plantaben Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ).

6700758-2 | Respiratory Failure, White Blood Cell Count Decreased
Patient was taking Hydrea (View Usage). After Hydrea was administered, patient had the following side effects: respiratory failure, white blood cell count decreased on Apr 22, 2010 from UNITED STATES Additional patient health information: Female patient , 40 years of age, was diagnosed with acute myeloid leukaemia and. Hydrea dosage: . During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ).

6690682-6 | Gastrooesophageal Reflux Disease
Adverse event was reported on Jan 25, 2010 by a Male patient taking Hydrea (View Usage) (Dosage: Route :g Tube) was diagnosed with laryngeal cancer, polycythaemia vera and. Location: UNITED STATES , 57 years of age, weighting 99.21 lb, Patient experienced the following unwanted or unexpected effects: gastrooesophageal reflux disease. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MOMETASONE FUROATE (View Mometasone Furoate Review and Mometasone Furoate Label ).

6690670-X | Blood Potassium Increased
on Jun 11, 2009 Female patient from UNITED STATES , 70 years of age, weighting 8.82 lb, was diagnosed with essential thrombocythaemia and was treated with Hydrea (View Usage). Patient had the following side effects: blood potassium increased. Hydrea dosage: Reduced To 400mg And Than To 300mg. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), ALLEGRA (View Allegra Review and Allegra Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), AMBIEN (View Ambien Review and Ambien Label ), CANDID B (View Candid B Review and Candid B Label ).

6690669-3 | Oedema Peripheral
on May 29, 2009 Female patient from UNITED STATES , 75 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Hydrea (View Usage). After Hydrea was administered, patient had the following side effects: oedema peripheral. Hydrea dosage: . During the same period patient was treated with GLEEVEC (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

6690667-X | Neuropathy Peripheral
Patient was taking Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: neuropathy peripheral on Apr 24, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 200.6 lb, was diagnosed with polycythaemia vera and. Hydrea dosage: Started Ten Years Ago. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), VIAGRA (View Viagra Review and Viagra Label ), ZYLOPRIM (View Zyloprim Review and Zyloprim Label ), FLOMAX (View Flomax Review and Flomax Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), RESTORIL (View Restoril Review and Restoril Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6690666-8 | Oedema Peripheral, Pain In Extremity, Rotator Cuff Syndrome
Adverse event was reported on Apr 22, 2009 by a Female patient taking Hydrea (View Usage) (Dosage: 2 Tablets Daily) was diagnosed with platelet count increased and. Location: UNITED STATES , 85 years of age, weighting 99.21 lb, Patient had the following side effects: oedema peripheral, pain in extremity, rotator cuff syndrome. During the same period patient was treated with TENORMIN (View Tenormin Review and Tenormin Label ), MAXIDEX (View Maxidex Review and Maxidex Label ), DILANTIN (View Dilantin Review and Dilantin Label ), PREVACID (View Prevacid Review and Prevacid Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), PROCARDIA (View Procardia Review and Procardia Label ), ZOCOR (View Zocor Review and Zocor Label ).

6690665-6 | Full Blood Count Decreased
on Apr 15, 2009 Male patient from UNITED STATES , 68 years of age, weighting 200.6 lb, was treated with Hydrea (View Usage). After Hydrea was administered, patient had the following side effects: full blood count decreased. Hydrea dosage: 10 Yrs Ago.. Patient was hospitalized.

6678275-8 | Renal Tubular Necrosis
on Apr 06, 2010 Male patient from FRANCE , child 6 years of age, was diagnosed with pain (What is pain?) and was treated with Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: renal tubular necrosis. Hydrea dosage: . During the same period patient was treated with IBUPROFEN (ADVIL) (View Ibuprofen (advil) Review and Ibuprofen (advil) Label ), EXJADE (View Exjade Review and Exjade Label ), ORACILLINE (View Oracilline Review and Oracilline Label ), FOLDINE (View Foldine Review and Foldine Label ). Patient was hospitalized.

6663469-8 | Actinic Keratosis, Basal Cell Carcinoma, Dermatomyositis, Skin Ulcer, Squamous Cell Carcinoma
Patient was taking Hydrea (View Usage). Patient had the following side effects: actinic keratosis, basal cell carcinoma, dermatomyositis, skin ulcer, squamous cell carcinoma on Mar 26, 2010 from FRANCE Additional patient health information: Male patient , 72 years of age, was diagnosed with essential thrombocythaemia and. Hydrea dosage: Initially At The Dose Of 17 Capsules A Week, Then, The Doses Varied Over Time. Patient was hospitalized.

6654796-9 | Platelet Count Increased, Red Blood Cell Count Increased
Adverse event was reported on Mar 23, 2010 by a Female patient taking Hydrea (View Usage) (Dosage: Since Jan2010 Capsule's Content Disssolved Into Coffee And Taken) was diagnosed with thrombocytosis and. Location: FRANCE , 82 years of age, After Hydrea was administered, patient had the following side effects: platelet count increased, red blood cell count increased.

6639873-0 | Renal Failure, Tumour Lysis Syndrome
on Mar 10, 2010 Female patient from JAPAN , 86 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure, tumour lysis syndrome. Hydrea dosage: .

6637479-0 | Splenomegaly
on Mar 09, 2010 Male patient from BRAZIL , 53 years of age, weighting 205.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with Hydrea (View Usage). Patient had the following side effects: splenomegaly. Hydrea dosage: Dose Decreased To Dosage Of 50mg And 100mg Intercalating Each Dose Per Day .interrupted On 7mar10.

6632208-9 | Infected Skin Ulcer
Patient was taking Hydrea (View Usage). After Hydrea was administered, patient had the following side effects: infected skin ulcer on Mar 04, 2010 from JAPAN Additional patient health information: Female patient , 72 years of age, weighting 114.6 lb, was diagnosed with essential thrombocythaemia and. Hydrea dosage: 1 Df=1000-1500mg/day;also On 17sep09. During the same period patient was treated with IMIDAPRIL HCL (Tabs) (View Imidapril Hcl Review and Imidapril Hcl Label ), BENZBROMARONE (Tabs) (View Benzbromarone Review and Benzbromarone Label ), FUROSEMIDE (Tabs) (View Furosemide Review and Furosemide Label ), AMLODIPINE BESYLATE (Tabs) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), METENOLONE (Acetate,tabs) (View Metenolone Review and Metenolone Label ). Patient was hospitalized.

6599873-6 | Infected Skin Ulcer
Adverse event was reported on Feb 17, 2010 by a Female patient taking Hydrea (View Usage) (Dosage: 1 Df=1000-1500mg/day.) was diagnosed with essential thrombocythaemia and. Location: JAPAN , 73 years of age, Patient experienced the following unwanted or unexpected effects: infected skin ulcer. Patient was hospitalized.

6554119-X | Cytolytic Hepatitis, Eosinophilia, Myocardial Infarction, Pneumonia Mycoplasmal, Renal Failure
on Jan 22, 2010 Male patient from FRANCE , 67 years of age, was diagnosed with essential thrombocythaemia, pulmonary embolism (What is pulmonary embolism?), thrombosis, lung disorder, dyslipidaemia and was treated with Hydrea (View Usage). Patient had the following side effects: cytolytic hepatitis, eosinophilia, myocardial infarction, pneumonia mycoplasmal, renal failure. Hydrea dosage: 10mar09 - 2may09 2 Months 16may09 - 20may09 5 D,dose Reduc To 2/d, Dechall:16may09,interrup:20may09. During the same period patient was treated with PREVISCAN (Interrupted On 28apr09 Restarted On 08-may-2009, Last Intake On 11-may-2009) (View Previscan Review and Previscan Label ), XAGRID (View Xagrid Review and Xagrid Label ), RULID (View Rulid Review and Rulid Label ), CALCIPARINE (View Calciparine Review and Calciparine Label ), TAHOR (View Tahor Review and Tahor Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6546267-5 | C-reactive Protein Increased, Nausea, Pyrexia
on Jan 13, 2010 Male patient from SWEDEN , 67 years of age, was diagnosed with polycythaemia vera and was treated with Hydrea (View Usage). After Hydrea was administered, patient had the following side effects: c-reactive protein increased, nausea (What is nausea?), pyrexia. Hydrea dosage: . During the same period patient was treated with APROVEL FILM COATED TABS 150 MG (View Aprovel Film-coated Tabs 150 Mg Review and Aprovel Film-coated Tabs 150 Mg Label ), TROMBYL (Tablets) (View Trombyl Review and Trombyl Label ), HUMALOG (Humalog Mix 25;100df=100iu/ml) (View Humalog Review and Humalog Label ), METFORMIN (View Metformin Review and Metformin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6543225-1 | C-reactive Protein Increased, Nausea, Pyrexia
Patient was taking Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, nausea (What is nausea?), pyrexia on Jan 15, 2010 from SWEDEN Additional patient health information: Male patient , 67 years of age, was diagnosed with polycythaemia vera and. Hydrea dosage: . During the same period patient was treated with APROVEL FILM COATED TABS 150 MG (View Aprovel Film-coated Tabs 150 Mg Review and Aprovel Film-coated Tabs 150 Mg Label ), TROMBYL (Tablets) (View Trombyl Review and Trombyl Label ), HUMALOG (Humalog Mix 25;100df=100iu/ml) (View Humalog Review and Humalog Label ). Patient was hospitalized.

6543212-3 | Haemolytic Anaemia
Adverse event was reported on Jan 08, 2010 by a Female patient taking Hydrea (View Usage) (Dosage: ) was diagnosed with thrombocytopenia and. Location: JAPAN , 84 years of age, Patient had the following side effects: haemolytic anaemia. During the same period patient was treated with ASPIRIN (Tabs) (View Aspirin Review and Aspirin Label ), RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ), METOPROLOL TARTRATE (Tabs) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), NIFEDIPINE (Tabs) (View Nifedipine Review and Nifedipine Label ), ISOSORBIDE MONONITRATE (Tabs) (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), OLMESARTAN MEDOXOMIL (Tabs) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized.

6541614-2 | Interstitial Lung Disease
on Jan 14, 2010 Female patient from JAPAN , 77 years of age, was treated with Hydrea (View Usage). After Hydrea was administered, patient had the following side effects: interstitial lung disease. Hydrea dosage: Dose Values :500*2 Mg/day,500*2 Mg/day 5 Days A Week,500*2 Mg/a Day 4days A Week..

6529754-5 | Angiocentric Lymphoma, B-cell Lymphoma, Epstein-barr Virus Infection, Skin Nodule
on Jan 04, 2010 Female patient from FRANCE , 86 years of age, was diagnosed with splenomegaly and was treated with Hydrea (View Usage). Patient experienced the following unwanted or unexpected effects: angiocentric lymphoma, b-cell lymphoma, epstein-barr virus infection, skin nodule. Hydrea dosage: . During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ). Patient was hospitalized.

6493370-4 | Angiocentric Lymphoma, Pulmonary Embolism
Patient was taking Hydrea (View Usage). Patient had the following side effects: angiocentric lymphoma, pulmonary embolism (What is pulmonary embolism?) on Dec 09, 2009 from JAPAN Additional patient health information: Male patient , 83 years of age, weighting 134.5 lb, was diagnosed with polycythaemia vera, myeloproliferative disorder, prophylaxis, angina pectoris, reflux oesophagitis, peripheral vascular disorder and. Hydrea dosage: 1 Df = 100mg Am And 500 Mg Pm. During the same period patient was treated with STEROIDS (View Steroids Review and Steroids Label ), ASPIRIN (Formulation: Tabs) (View Aspirin Review and Aspirin Label ), NITROGLYCERIN (Formulation: Tape) (View Nitroglycerin Review and Nitroglycerin Label ), OMEPRAZOLE (Formulation: Tabs) (View Omeprazole Review and Omeprazole Label ), TOCOPHEROL ACETATE (Formulation: Tab) (View Tocopherol Acetate Review and Tocopherol Acetate Label ). Patient was hospitalized.